Mode
Text Size
Log in / Sign up
Phase 4 Completed N=26 Randomized Quadruple-blind Treatment

Methylphenidate for Attention Problems After Pediatric TBI

Source: ClinicalTrials.gov NCT01933217 ↗
Enrolled (actual)
26
Serious AEs
2.5%
Results posted
Jun 2020
Primary outcomePrimary: Parent Outcome-Vanderbilt ADHD Parent Rating Scales (VADPRS) — 1.10; 1.47; .84; 1.14 units on a scale
◆ Published Evidence
Established
22citations · ~3 / year
Benefits of Methylphenidate for Long-Term Attention Problems After Traumatic Brain Injury in Childhood: A Randomized, Double-Masked, Placebo-Controlled, Dose-Titration, Crossover Trial.
The Journal of head trauma rehabilitation · 2019 · Likely link

Summary

Traumatic Brain Injury (TBI) - methylphenidate treatment

Linked Publications

  • Benefits of Methylphenidate for Long-Term Attention Problems After Traumatic Brain Injury in Childhood: A Randomized, Double-Masked, Placebo-Controlled, Dose-Titration, Crossover Trial.
    The Journal of head trauma rehabilitation · 2019 · 22 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Parent Outcome-Vanderbilt ADHD Parent Rating Scales (VADPRS)
1.10; 1.47; .84; 1.14; 1.37; 1.79
PRIMARY
Parent Outcome-Behavior Rating Inventory of Executive Functioning (BRIEF)
60.05; 65.20; 54.30; 58.00; 62.40; 67.75
SECONDARY
Neuropsychological Outcome- Wechsler Intelligence Scale for Children, 4th Edition Processing Speed Index (WISC-IV-PSI)
96.05; 91.25
SECONDARY
Teacher Outcome Measure

Eligibility Criteria

Inclusion Criteria

  • Between ages of 6-17
  • Sustained Moderate to Severe TBI
  • TBI occurred at least 6 months prior to beginning the study
  • TBI occurred no earlier than 5 years of age
  • Positive endorsement of 6 out of 9 items on the Vanderbilt ADHD inattention or hyperactivity scale

Exclusion Criteria

  • History of developmental disability or mental retardation
  • Current active participation in ADHD-related behavioral intervention
  • History of psychiatric condition requiring an inpatient admission in past 12 months
  • Actively taking medications with a contraindication to Concerta that cannot be discontinued
  • Current use of stimulant medication or ADHD specific medications that cannot be discontinued
  • Non-blunt head injury
  • Family history of arrhythmia
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01933217) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search